Liver transplantation (OLT) for hepatocellular carcinoma (HCC): Role of selection and multimodal chemotherapy

被引：0
|
作者：
Buda, A [1 ]
Destro, C [1 ]
Burra, P [1 ]
Angeli, P [1 ]
Farinati, F [1 ]
Zanus, G [1 ]
Merenda, R [1 ]
Neri, D [1 ]
Gerunda, G [1 ]
Naccarato, R [1 ]
Fagiuoli, S [1 ]
机构：
[1] Univ Padua, Dept Organ Transplantat, Padua, Italy
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0059
引用
收藏
页码：A1193 / A1193
页数：1
相关论文
共 50 条
  • [21] Multimodal anticancer therapy and liver transplantation for hepatocellular carcinoma
    Königsrainer A.
    Hochleitner B.W.
    Acta Chirurgica Austriaca, 1998, 30 (4) : 225 - 226
  • [22] Predictors of the development of de novo hepatocellular carcinoma (HCC) in patients awaiting orthotopic liver transplantation (OLT) during the meld era
    Brady, Carla W.
    Smith, Alastair D.
    Stechuchak, Karen M.
    Coffman, Cynthia J.
    Tuttle-Newhall, Janet E.
    Provenzale, Dawn
    Muir, Andrew J.
    HEPATOLOGY, 2006, 44 (04) : 506A - 507A
  • [23] Multimodal therapy before liver transplantation for hepatocellular carcinoma
    Vitale, A
    Brolese, A
    Zanus, G
    Bassanello, M
    Montin, U
    Gringeri, E
    D'Amico, F
    Ciarleglio, FA
    Carraro, A
    Cappuzzo, G
    Bridda, A
    D'Amico, DF
    Cillo, U
    HEPATOLOGY RESEARCH, 2005, 31 (02) : 112 - 115
  • [24] HEPATOCELLULAR CARCINOMA (HCC) IS THE MAIN INDICATION FOR LIVER TRANSPLANTATION (OLT) AMONG HBV PATIENTS IN THE ERA OF NUCLEOS/TIDE ANALOGUE THERAPIES
    Han, Steven-Huy B.
    Reddy, K. Rajender
    Keeffe, Emmet B.
    Soldevila-Pico, Consuelo
    Gish, Robert G.
    Chung, Raymond T.
    Degertekin, Bulent
    Lok, Anna S. F.
    HEPATOLOGY, 2008, 48 (04) : 946A - 947A
  • [25] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Health-related quality of life in patients with chronic liver disease with or without hepatocellular carcinoma (HCC) awaiting orthopic liver transplantation (OLT)
    Casanovas, Teresa
    Jane, Laia
    Herdman, Michael
    Casado, Alfonso
    Fabregat, Joan
    HEPATOLOGY, 2007, 46 (04) : 560A - 560A
  • [27] The Role of Liver Transplantation in Hepatocellular Carcinoma
    Jakhete, Neha
    Majeed, Nehna Abdul
    Maluf, Daniel
    Shetty, Kirti
    CLINICS IN LIVER DISEASE, 2025, 29 (01) : 73 - 85
  • [28] Role of Liver Transplantation for Hepatocellular Carcinoma
    Kumaran, Vinay
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2014, 4 : S97 - S103
  • [29] Selection of patients with hepatocellular carcinoma for liver transplantation
    Sutcliffe, R
    Maguire, D
    Portmann, B
    Rela, M
    Heaton, N
    BRITISH JOURNAL OF SURGERY, 2006, 93 (01) : 11 - 18
  • [30] Predictors of disease recurrence following chemoembolization, liver transplantation (OLT), and adjuvant chemotherapy for hepatoma (HCC).
    Morgan, GR
    Goldenberg, A
    Rosen, R
    Diflo, T
    John, D
    Teperman, L
    TRANSPLANTATION, 1999, 67 (09) : S579 - S579
12345